Evidence map›Paper›PMID 31222467›Full record

ArticleBotanical studies2019

Characteristics of mitosis in the gametophyte cells of the marine green alga Monostroma angicava.

Yusuke Horinouchi, Tatsuya Togashi

Open access · goldAbstract read
In one paragraph

Article in Botanical studies, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yusuke HorinouchiMarine Biosystems Research Center, Chiba University, Kamogawa, 299-5502, Japan.
Tatsuya TogashiMarine Biosystems Research Center, Chiba University, Kamogawa, 299-5502, Japan. togashi@faculty.chiba-u.jp.
Chiba University · JP

Funding

Japan Society for the Promotion of Science 15K14598Japan Society for the Promotion of Science 16H04839Japan Society for the Promotion of Science 25257460Japan Society for the Promotion of Science 25291097
6 · The paper itself

Abstract

backgroundSome marine algae exhibit several characteristics of mitosis (e.g., the timing of mitosis such as diurnal periodicity) that are unique from those of land plants. Not only the timing but also other characteristics of mitosis, including the process itself and the number of chromosomes involved, are largely unknown in ulvophycean marine green algae. Effective mitotic inhibitors are useful for observing mitosis and identifying the number of chromosomes. However, few such inhibitors are available for ulvophycean algae. Here, we examined the timing and process of mitosis and the number of chromosomes with several mitotic inhibitors in the haploid gametophyte cells of the Ulvophyceae alga Monostroma angicava.

resultsMitosis did not occur during the light period but began immediately after the onset of the dark period. The typical process of mitosis was observed. The mitotic inhibitors colchicine and 8-hydroxyquinoline, which generally arrest mitosis in land plants, were ineffective in M. angicava. We found that three other mitotic inhibitors, amiprophos methyl, griseofulvin and oryzalin, are effective to arrest mitosis. With three-dimensional fluorescence microscopy, we demonstrated that there were nine chromosomes in each cell.

conclusionsIn the gametophyte cells of M. angicava, mitosis occurs diurnally. It is triggered by the onset of the dark period. We identified the number of chromosomes as N = 9. Our study shows effective inhibitors to observe mitosis in ulvophycean algae.

Indexed as

Chromosome numberDiurnal periodicityGametophyteMetaphase arrestMitosisUlvophyceae

Identifiers

PMID31222467
PMCPMC6586733
OpenAlexW2952880868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.